Skip to side navigation Skip to content
The California State University


  • Moore, C., J. Sidney, A. English, A. Wriston, D. Hunt, J. Shabanowitz, S. Southwood, K. Bradley, B. Lafont and B. Mothe. 2012. Identification of the peptide-binding motif recognized by the pigtail macaque class I MHC molecule Mane-A1*082. Immunogenetics 64: 461-468.

  • Sette, A., J. Sidney, S. Southwood, C. Moore, J. Berry, C. Dow, K. Bradley, I. Hoof, M. Lewis and W. Hildebrand. 2012. shared MHC supertype motif emerges by convergent evolution in macaques and mice, but is totally absent in human MHC molecules. Immunogenetics 64: 421-434.

  • Southwood, S., C. Solomon, I. Hoof, R. Rudersdorf, J. Sidney, B. Peters, A. Wahl, O. Hawkins, W. Hildebrand and B. Mothe. 2011. Functional analysis of frequently expressed Chinese rhesus macaque MHC class I molecules Mamu-A102601 and Mamu-B08301 reveals HLA-A2 and HLA-A3 supertypic specificities. Immunogenetics 63: 275-290.

  • Wambua, D., R. Henderson, C. Solomon, M. Hunter, P. Marx, A. Sette and B. Mothe. 2011. SIV-infected Chinese-origin rhesus macaques express specific MHC class I alleles in either elite controllers or normal progressors. Journal of Medical Primatology 40: 244-247.

  • Solomon, C., S. Southwood, I. Hoof, R. Rudersdorf, B. Peters, J. Sidney, C. Pinilla, M. Marcondes, B. Ling and P. Marx. 2010. most common Chinese rhesus macaque MHC class I molecule shares peptide binding repertoire with the HLA-B7 supertype. Immunogenetics: 451-464.

  • Botten, J., J. Sidney, B. Mothe, B. Peters, A. Sette and M. Kotturi. 2010. Coverage of Related Pathogenic Species by Multivalent and Cross-Protective Vaccine Design. Microbiology & Molecular Biology Reviews 74: 1-1.

  • Walsh, S., J. Gillis, B. Peters, B. Mothe, J. Sidney, A. Sette and R. Johnson. 2009. Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques. Vaccine 27: 4990-5000.

  • Dow, C., C. Oseroff, B. Peters, C. Nance-Sotelo, J. Sidney, M. Buchmeier, A. Sette and B. Mothe. 2008. Lymphocytic Choriomeningitis Virus Infection Yields Overlapping CD4. Journal of Virology 82: 11734-11741.

  • Wang, P., J. Sidney, C. Dow, B. Mothé, A. Sette and B. Peters. 2008. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS computational biology: e1000048.

  • Dow, C., C. Oseroff, B. Peters, C. Nance-Sotelo, J. Sidney, M. Buchmeier, A. Sette and B. Mothé. 2008. LCMV infection yields overlapping CD4+ and CD8+ T-cell responses. Journal of virology.

  • Sette, A., J. Sidney, H. Bui, M. Guercio, J. Alexander, J. Loffredo, D. Watkins and B. Mothe. 2005. Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity. Immunogenetics 57: 53-68.

  • Geisbert, T., S. Jones, E. Fritz, A. Shurtleff, J. Geisbert, R. Liebscher, A. Grolla, U. Stroher, L. Fernando and K. Daddario. 2005. Development of a New Vaccine for the Prevention of Lassa Fever. PLoS Medicine 2: 0537-0545.

  • Friedrich, T., E. Dodds, L. Yant, L. Vojnov, R. Rudersdorf, C. Cullen, D. Evans, R. Desrosiers, B. Mothe and J. Sidney. 2004. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nature Medicine: 275-281.

  • Mothe, B., J. Weinfurter, C. Wang, W. Rehrauer, N. Wilson, T. Allen, D. Allison and D. Watkins. 2003. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. Journal of Virology: 2736-2740.

  • O'Connor, D., T. Allen, T. Vogel, P. Jing, I. DeSouza, E. Dodds, E. Dunphy, C. Melsaether, B. Mothe and H. Yamamoto. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nature Medicine: 493-499.

  • Allen, T., D. O'Connor, P. Jing, J. Dzuris, B. Mothe, T. Vogel, E. Dunphy, M. Liebl, C. Emerson and N. Wilson. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390.

return to top